[ad_1]
release date
The three teams will report to the Innovation Fund Advisory Committee in May. Seen here is Fall 2023 finalist Nick Famster.
Spring 2024 George Schulz Innovation Fund finalists are developing solutions to detect lead in water, treat disease, and improve patient care.
The George Shultz Innovation Fund, managed by the Polsky Center for Entrepreneurship and Innovation, will co-invest up to $250,000 in early-stage technology ventures from the University of Chicago, Argonne National Laboratory, Fermilab, and the Marine Biological Laboratory. provide funding.
Register for the George Schultz Innovation Fund Final >>
Each team will make a proposal to the Innovation Fund Advisory Board, comprised of advisors, entrepreneurs, and industry experts, during the final event on Wednesday, May 29, 2024.
The Spring 2024 finalists are:
nanoaffix science // NanoAffix has developed a portable device for real-time detection of lead in tap water. The system consists of a handheld sensor module connected to a mobile app via Bluetooth. Their long-term solution is an in-line continuous sensor chip integrated with the water filter.
- CEO Junhong Chen, Crown Family Professor of Molecular Engineering, Pritzker School of Molecular Engineering, and Chief Water Strategist at Argonne National Laboratory
Claudine Biotech // Claudyn Biotech is developing a new class of drugs that block claudin channels that can be used to treat diseases such as inflammatory bowel disease.
- Co-founder Chris Weber is an associate professor of pathology. Le Shen, Associate Professor of Surgical Research;Fatemeh Khalili Araghi, University of Illinois at Chicago
PAC dynamic // Using computational modeling and machine learning algorithms in combination with proprietary algorithms, we can model a variety of treatment options to maximize care for heart failure patients.
To date, the Innovation Fund has invested more than $9 million in more than 90 companies and raised more than $412 million in subsequent funding. Companies established with the support of the fund include Onchilles Pharma, ExplORer Surgical, ClostraBio, Esya Labs, and Super.Tech.
The Innovation Fund’s core mission is to help scientific founders turn their innovations into ventures that advance cutting-edge technology, generate significant economic returns, and have a lasting impact on humanity. is.
[ad_2]
Source link
